473049
(1S,4S)-(−)-2-Boc-2,5-diazabicyclo[2.2.1]heptane
95%
Synonym(s):
tert-Butyl (1S,4S)-(−)-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate
Sign Into View Organizational & Contract Pricing
All Photos(2)
About This Item
Recommended Products
Quality Level
Assay
95%
optical activity
[α]22/D −44°, c = 1 in chloroform
mp
74-76 °C (lit.)
SMILES string
CC(C)(C)OC(=O)N1C[C@@H]2C[C@H]1CN2
InChI
1S/C10H18N2O2/c1-10(2,3)14-9(13)12-6-7-4-8(12)5-11-7/h7-8,11H,4-6H2,1-3H3/t7-,8-/m0/s1
InChI key
UXAWXZDXVOYLII-YUMQZZPRSA-N
Related Categories
Application
(1S,4S)-(-)-2-Boc-2,5-diazabicyclo[2.2.1]heptane may be used in the preparation of 2-boc-5-(4-nitrophenyl)-2,5-diaza-bicyclo[2.2.1]heptane by reacting with p-nitrobenzene.
It may also be used to develop:
It may also be used to develop:
- indazolylpyrazolo[1,5-a]pyrimidine analogs based B-Raf inhibitors
- CCR2 antagonists
- α4β2 nicotinic acetylcholine receptor (nAChR) partial agonists
- azabicyclic sulfonamide based 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Synthesis and biological evaluation of novel hybrids of highly potent and selective a4?2-Nicotinic acetylcholine receptor (nAChR) partial agonists.
European Journal of Medicinal Chemistry, 124, 689-697 (2016)
Indazolylpyrazolopyrimidine as highly potent B-Raf inhibitors with in vivo activity.
Journal of Medicinal Chemistry, 53(21), 7874-7878 (2010)
Azabicyclic sulfonamides as potent 11?-HSD1 inhibitors.
Bioorganic & Medicinal Chemistry Letters, 20(5), 1551-1554 (2010)
Design and synthesis of novel CCR2 antagonists: Investigation of non-aryl/heteroaryl binding motifs.
Bioorganic & Medicinal Chemistry Letters, 21(6), 1827-1831 (2011)
4-(Phenylaminomethylene) isoquinoline-1, 3 (2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4 (CDK4).
Journal of Medicinal Chemistry, 51(12), 3507-3525 (2008)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service